Successful treatment of visceral leishmaniasis with liposomal amphotericin B

Acta Biomed. 2006:77 Suppl 2:22-5.

Abstract

We report a case of a 26-year-old female from Kenya who suffered from intermittent fever of unknown origin for one month. The major findings on admission were pancytopenia associated with considerable splenomegaly. The diagnosis was established by visualisation of amastigotes in bone marrow biopsy and by detection of antibodies to Leishmania spp. in blood. The infection was treated intravenously with liposomal amphotericin B for five days. The patient was afebrile after the first infusion. No relapse was reported.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Amphotericin B / administration & dosage
  • Amphotericin B / therapeutic use*
  • Antiprotozoal Agents / administration & dosage
  • Antiprotozoal Agents / therapeutic use*
  • Austria
  • Female
  • Fever / etiology
  • Humans
  • Kenya / ethnology
  • Leishmaniasis, Visceral / blood
  • Leishmaniasis, Visceral / complications
  • Leishmaniasis, Visceral / diagnosis
  • Leishmaniasis, Visceral / drug therapy*
  • Liposomes
  • Remission Induction

Substances

  • Antiprotozoal Agents
  • Liposomes
  • liposomal amphotericin B
  • Amphotericin B